Marcus A. Horwitz, MD, former chief of the Division of Infectious Diseases at UCLA’s David Geffen School of Medicine, will deliver the Medicine Grand Rounds lecture as a special guest speaker Jan. 31, noon-1 p.m., COM-T Room 5403, on the topic: “Fighting the World's Leading Infectious Killer: Advances in Diagnosis, Treatment and Prevention of TB.”
His talk will be simulcast at Banner – University Medical Center South, Conference Room 3030, 2800 E. Ajo Way, Tucson. Others can watch it live at this link.
To add this event to your personal schedule (via iCal, Outlook, Google, or Yahoo! calendar), click here then on “Add to Calendar.”
Two of the latest articles by Dr. Horwitz, a renowned researcher on the tuberculosis, on the subject include:
- “Listeria-vectored vaccine expressing the Mycobacterium tuberculosis 30 kDa major secretory protein via the constitutively active prfA regulon boosts BCG efficacy against tuberculosis,” Infection & Immunity, June 2017, PMID: 28630063, and
- “Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time,” Nature Communications, January 2017, PMID: 28117835 | Free PMC Article.
Dr. Horwitz received his bachelor’s degree in physics from Cornell University in 1968, and his medical degree from Columbia University College of Physicians and Surgeons in 1972. Subsequently, he trained in internal medicine and infectious diseases at Albert Einstein College of Medicine and served for two years as an epidemic intelligence officer at the U.S. Centers for Disease Control and Prevention (CDC). From 1977-1980, he did post-doctoral training in basic laboratory research in the Laboratory of Cellular Physiology and Immunology at The Rockefeller University. From 1980-85, he served on the faculty of there as an assistant professor and associate physician. In 1985, he joined the faculty of the University of California, Los Angeles (UCLA) as professor of medicine and of microbiology, immunology and molecular genetics and as infectious diseases chief—a position he held until 1992.
Dr. Horwitz is a fellow in the Infectious Diseases Society of America and a member of the American Society for Clinical Investigation. His awards include the Oswald Avery (formerly Squibb) Award for Outstanding Research in Infectious Diseases from the Infectious Diseases Society of America and election to Fellowship in the American Association for the Advancement of Science. He has served as chairman of the Scientific Advisory Board of the American Leprosy Foundation, on the Tuberculosis Panel of the U.S.-Japan Cooperative Medical Sciences Program, on the board of trustees of the Trudeau Institute, as an advisor to the World Health Organization Global Forum on TB Vaccines Research and Development, and on the Cornell University Life Sciences Advisory Board. He has been on the editorial boards of Infection and Immunity and The Journal of Clinical Investigation, a journal for which he has also served as guest editor.
His research has focused on intracellular parasitism, especially the immunobiology of the etiologic agents of Legionnaires' disease, leprosy, tuberculosis, and tularemia and the development of vaccines and nanotherapeutics against these pathogens. He has also developed drugs against cardiovascular diseases, complications of transplantation, and iron overload. He has 21 issued U.S. patents and numerous accompanying foreign patents on technologies developed in his laboratory.
Department of Medicine Grand Rounds
Grand Rounds lectures for the UA Department of Medicine, the largest department in the UA College of Medicine – Tucson, occur on Wednesdays, noon-1 p.m., COM-T Room 5403—largely during the academic year. It also is simulcast at Banner – UMC South in Conference Room 3030. All such lectures are archived for future viewing here: http://streaming.biocom.arizona.edu/categories/?id=10
The UA College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The UA College of Medicine - Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All Faculty, CME Planning Committee Members, and CME Office Reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.
- Diagnose a variety of internal medicine illnesses
- Understand more clearly advances in therapy
- Become truly professional physicians
Contact: Claudia R. Duran, email@example.com